Research Partnership's new report on living with rheumatoid arthritis (RA) is aimed at "helping pharmaceutical companies understand the attitudes and unmet needs of people with RA and how current market dynamics, with the advent of new biologics/biosimilars and oral JAK inhibitors, have affected patients’ views and behaviours towards their RA". Living with Rheumatoid Arthritis (RA) is based on 431 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK), 56 patients in Japan, and 112 patients in Canada. The study consists of 30-minute quantitative online and qualitative telephone interviews with patients. Research Partnership's Mariel Metcalfe commented: “An inescapable characteristic of RA is that it is unpredictable and can highly impact patients’ practical and emotional lives. While the range of RA treatments has grown, it is even more important to understand and measure how patients view these treatments and if they are truly meeting their needs.” Living with RA is one in a series of "Living With" reports offering insight into the chronic disease patient journey from pre-diagnosis to stabilization, which include Atopic Dermatitis (EU & US), Psoriasis (EU), NASH (EU & US) and Diabetes LATAM. www.researchpartnership.com/livingwith
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.